Amwell appoints Robert Webb to Board of Directors effective October 31, 2022

American Well Corp

Robert Webb appointed as Class I director; term ends at 2024 annual meeting.
Webb former CEO of Optum's consumer business and President of UnitedHealth Group Ventures.
Independent director per NYSE standards; no material transactions with Amwell.
Brings over 30 years of health tech leadership; eligible for non-employee director compensation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Webb

Class I director

AMWL · American Well Corp

Effective: 2022-10-31
Filed: November 3, 2022, 7:59 PM ET

Effective October 31, 2022, the Board of Directors (the " Board ") of American Well Corporation (the " Company ") appointed Robert Webb as a Class I director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert Webb was appointed as Class I director at American Well Corp.

Action: appointed
Role: Class I director

Exact text from the filing

Effective October 31, 2022, the Board of Directors (the " Board ") of American Well Corporation (the " Company ") appointed Robert Webb as a Class I director of the Company.

View on SEC.gov

American Well Corp filing history →

Source: SEC EDGAR

accession 0000950170-22-021924

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.